ASRS
NRIX icon

Arizona State Retirement System’s Nurix Therapeutics NRIX Stock Holding History

Arizona State Retirement System’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Sell
17,120
-3,763
-18% -$64.1K ﹤0.01% 1620
2026
Q1 		$324K Sell
20,883
-1,107
-5% -$18.4K ﹤0.01% 1686
2025
Q4 		$417K Buy
21,990
+1,674
+8% +$24K ﹤0.01% 1578
2025
Q3 		$188K Buy
20,316
+312
+2% +$3.24K ﹤0.01% 1972
2025
Q2 		$228K Buy
20,004
+2,751
+16% +$29.7K ﹤0.01% 1858
2025
Q1 		$205K Buy
17,253
+1,385
+9% +$23.2K ﹤0.01% 1876
2024
Q4 		$299K Buy
15,868
+104
+0.7% +$2.38K ﹤0.01% 1759
2024
Q3 		$354K Buy
15,764
+1,650
+12% +$37.4K ﹤0.01% 1671
2024
Q2 		$295K Buy
+14,114
New +$220K ﹤0.01% 1713
2023
Q4 		– Sell
-10,980
Closed -$86.3K – 2178
2023
Q3 		$86.3K Sell
10,980
-347
-3% -$3.17K ﹤0.01% 2096
2023
Q2 		$113K Buy
11,327
+1,082
+11% +$11K ﹤0.01% 2099
2023
Q1 		$91K Buy
+10,245
New +$107K ﹤0.01% 2130

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arizona State Retirement System's NRIX Position: Q2 2026 in Review

Arizona State Retirement System reduced its Nurix Therapeutics (NRIX) stake by 18% in Q2 2026, selling an estimated $64.1K and leaving 17,120 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Arizona State Retirement System first reported a position in NRIX in Q1 2023 and has held it in 12 quarters since. The position peaked at $417K in Q4 2025. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Arizona State Retirement System held 17,120 shares of Nurix Therapeutics worth $415K as of Q2 2026.
  • Arizona State Retirement System sold 3,763 Nurix Therapeutics shares in Q2 2026, an estimated $64.1K.
  • Nurix Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1620 holding.
  • Arizona State Retirement System first reported a position in Nurix Therapeutics in Q1 2023 and has held it in 12 quarters since.
  • Arizona State Retirement System's Nurix Therapeutics position peaked at $417K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.